Active ingredientChlorzoxazoneCat. No. P-C149-001CAS 95-25-0Family · Pharmaceutical analytical standards
Chlorzoxazone
A centrally acting muscle relaxant of the benzoxazolone family, patented in the United States in 1959 and used for muscle spasms and the pain they cause. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.
Did you know?In pharmacology it also serves as a 'probe': since it is transformed by the liver enzyme CYP2E1, measuring its metabolism makes it possible to estimate that enzyme's activity in clinical studies.
Go to the active ingredient →Active ingredientChlorzoxazoneCat. No. P-C149-001CAS 95-25-0
Pharmacopoeial impurityChlorzoxazone USP Related Compound ACat. No. P-C149-002CAS 95-85-2
MetaboliteChlorzoxazone N-GlucuronideCat. No. P-C149-003
MetaboliteChlorzoxazone O-GlucuronideCat. No. P-C149-004
Isotopically labelled6-Hydroxy Chlorzoxazone-d2Cat. No. P-C149-006CAS 1432065-00-3
Isotopically labelledChlorzoxazone-d3Cat. No. P-C149-009CAS 1185173-60-7
Impurity2(3H)-BenzoxazoloneCat. No. P-C149-010CAS 59-49-4
Impurity6-Hydroxy ChlorzoxazoneCat. No. P-C149-011CAS 1750-45-4
ImpurityChlorzoxazone 2-Hydroxy ImpurityCat. No. P-C149-012
ImpurityChlorzoxazone Dimer ImpurityCat. No. P-C149-013
ImpurityChlorzoxazone Impurity 1Cat. No. P-C149-014
ImpurityChlorzoxazone Impurity 2Cat. No. P-C149-015No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.